Gliosarcoma Case Report and Review of the Literature

References

• Ströbe H. Über Entstehung und Bau der Gehirngliome. Beitr Pathol Anat Allg Pathol 1895; 18: 405–86
   Google Scholar
• Feigin I M, Gross S W. Sarcoma arising in glioblastoma of the brain. Am J Pathol 1955; 31: 633–65
   PubMedGoogle Scholar
• Kleihues P, Burger P C, Scheithauer B W. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255–68
   PubMed Web of Science ®Google Scholar
• Meis J M, Martz K L, Nelson J S. Mixed glioblastoma multiforme and sarcoma. Cancer 1991; 67: 2342–9
   PubMed Web of Science ®Google Scholar
• Morantz R A, Feigin I, Ransohoff I J, II. Clinical and pathological study of 24 cases of gliosarcoma. J Neurosurg 1976; 45: 398–408
   PubMed Web of Science ®Google Scholar
• Banaerjee A K, Sharma B S, Kak V K, Ghatak N R. Gliosarcoma with cartilage formation. Cancer 1989; 63: 518–23
   PubMedGoogle Scholar
• Tada T, Katsuyama T, Aoki T, Kobayashi S, Shigematsu H. Mixed glioblastoma and sarcoma with osteoid-chondral tissue. Clin Neuropathol 1987; 6: 160–3
   PubMedGoogle Scholar
• Hayashi K, Ohara N, Jeon H J, et al. Gliosarcoma with features of chondrblastic osteosarcoma. Cancer 1993; 72: 850–5
   PubMedGoogle Scholar
• Barnard R O, Bradford T S, Thomas D GT. Gliomyosarcoma: report of a case of rhabdomyosarcoma arising in malignant glioma. Acta Neuropathol 1986; 69: 23–7
   PubMedGoogle Scholar
• Grant J W, Steart P V, Aguzzi A, Jones D B, Gallagher P J. Gliosarcoma: an immunohistochemical study. Acta Neuropathol 1989; 79: 305–9
   PubMed Web of Science ®Google Scholar
• Ho K L. Histogenesis of sarcomatous components of the gliosarcoma: an ultrastructural study. Acta Neuropathol 1990; 81: 178–88
   PubMedGoogle Scholar
• Tamura T, Nakamura S, Shirata K, Sato K, Tsubokawa T, Sawada T. Cerebellar malignant glioma after radiation therapy for suprasellar germinoma. Neurol Med Chir (Tokyo) 1989; 29: 223–9
   PubMedGoogle Scholar
• Takaue Y, Sullivan M P, Ramirez I, Cleary K R, Eys J. Second malignant neoplasm in treated Hodkin's disease. AJDC 1986; 140: 49–51
   PubMedGoogle Scholar
• Beute B J, Fobben E S, Hubschmann O, Zablow A, Eanelli T, Solitaire G B. Cerebellar gliosarcoma: report of a radiation-induced neoplasm. AJNR 1991; 12: 554–6
   PubMedGoogle Scholar
• Wargotz E S, Sidawy M K, Janotta F S. Thorotrats-associated gliosarcoma. Cancer 1988; 62: 58–66
   PubMedGoogle Scholar
• Garrett P. Glioblastoma and fibroblastoma of the brain with extracranial metastases. Cancer 1958; 11: 888–94
   PubMedGoogle Scholar
• Smith D R, Hardman J M, Earle K M. Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis. Cancer 1969; 24: 270–6
   PubMed Web of Science ®Google Scholar
• Weaver D, Vanden Berg S R, Park T S, Jane J A. Selective peripancreatic sarcoma metastases from primary gliosarcoma. J Neurosurg 1984; 61: 599–601
   PubMed Web of Science ®Google Scholar
• Cerame M A, Guthikonda M, Kohli C M. Extraneural metastases in gliosarcoma: a case report and review of the literature. Neurosurgery 1985; 17: 413–8
   PubMed Web of Science ®Google Scholar
• Kimler B F. The 9L rat brain tumour model for pre-clinical investigation of radiation-chemotherapy interactions. J Neurol Oncol 1994; 20: 103–9
   PubMedGoogle Scholar
• Walker M D, Greed S B, Byar D P. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl Med 1980; 303: 1323–9
   PubMed Web of Science ®Google Scholar
• Levin V A, Silver P, Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PVC) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 1990; 18: 321–4
   PubMed Web of Science ®Google Scholar
• Kimler B F, Liu C, Evans R G, Morantz R A. Combination of aziridinylbenzoquinone and cisplatinum with radiation therapy in the 9L rat brain tumour model. Int J Radiat Oncol Biol Phys 1993; 26: 445–50
   PubMedGoogle Scholar
• Vats T S, Morantz R A, Wood G W, Tilzer S. Study of effectiveness of bleomycin in rat brain tumour model intravenously and intracerebrally. Int J Radiat Oncol Biol Phys 1979; 5: 1527–9
   PubMedGoogle Scholar
• Bamberg M, Budach V, Stuschke M, Gerhard L. Preliminary experimental results with the nitrosourea derivative ACNU in the treatment of malignant gliomas. Radiother Oncol 1988; 12: 25–9
   PubMedGoogle Scholar
• Barker M, Deen D F, Baker D G. BCNU and X-ray therapy of intracerebral 9L rat tumours. Int J Radiat Oncol Biol Phys 1979; 5: 1581–3
   PubMed Web of Science ®Google Scholar
• Furuta T, Fujiwara T, Rosenfeld S A, Wilkinson H A. Synergistic effect of methotrexate and radiation on gliosarcoma in tissue culture and in rats. Neurosurgery 1986; 18: 596–603
   PubMedGoogle Scholar
• Wilkinson H A, Fujiwara T, Rosenfeld S. Synergistic effect between intraneoplastic methotrexate and radiation on experimental intracerebral rat gliosarcoma. Neurosurgery 1994; 24: 665–8
   Google Scholar
• Kruse C A, Schiltz P M, Bellgrau D, Kong Q, Kleinschmidt-DeMasters B K. Intracranial administration of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumours. J Neuro Oncol 1994; 19: 161–8
   PubMedGoogle Scholar
• Schütte J, Kellner R, Seeber S. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West Germany Tumour Center, Essen. Cancer Chemother Pharmacol 1993; 31((Suppl 2))194–8
   Google Scholar
• Wiltshaw E, Westbury G, Harmer C, McKinna A, Fisher C. Ifosfamide plus mesna with and without Adriamycin in soft tissue sarcoma. Cancer Chemother Pharmacol 1986; 18((Suppl 2))10–2
   Google Scholar
• Jager A H, Bogdahn U, Apfel R, Pfeufer B, Dekant A. In vitro studies on the interaction of 4-hydroxyifosfamide and 2-mercaptoethanesulphonate in malignant glioma. J Cancer Res Clin Oncol 1993; 119: 721–6
   PubMedGoogle Scholar